Actos Bellwether Trial Update: First Federal Trial to Commence on 1/27/14
Takeda, the manufacturer of the dangerous diabetes medication Actos, is facing it’s first federal bellwether trial on January 27, 2014. This trial could pave the way for justice and settlements for the thousands of Americans who suffered bladder cancer while taking Actos. In significant rulings, the Court denied challenges by Takeda to plaintiff’s scientific evidence […]
Advice For Dealing With Your Diagnosis, From an Actos Bladder Cancer Victim Lawyer
If you were diagnosed with bladder cancer while using the diabetes drug Actos, your losses extend far beyond the medical costs, pain and lost time during your treatment and recovery. Since bladder cancer has a high rate of recurrence, you will be dealing with this for years to come as you endure follow-up tests and […]
STUDY CONFIRMS THE INCREASED RISK OF BLADDER CANCER WITH ACTOS (PIOGLITAZONE)
The British Medical Journal recently published results from a study providing evidence that Actos (pioglitazone), an oral antidiabetic agent in the thiazolidinedione class, is associated with an increased risk of bladder cancer. The cohort included 115,727 diabetics newly treated with oral hypoglycemic agents between 1988 and 2009. The study criteria excluded patients who were below […]
Canadian Study Finds an 83% Increased Risk of Bladder Cancer in Actos Users
In a new Canadian study recently published in the British Medical Journal on the side effects of Actos, it was reported that people being treated for type 2 diabetes with Takeda Pharmaceutical’s drug Actos may be putting themselves at risk for bladder cancer. Lead researcher Laurent Azoulay and her team colleted data on 115,727 patients […]
An Explanation of How Actos Lawsuits Are Handled In State Courts and Federal Courts
Earlier this year, the public was alerted that the diabetes medication, Actos, causes bladder cancer. It did not take long for the FDA and the public to discover that the manufacturer of Actos tragically failed to adequately warn and properly study the risk of bladder cancer. Takeda, the manufacturer of Actos, deprived physicians of the […]
Background Information about Actos and Bladder Cancer
ACTOS ASSOCIATION WITH BLADDER CANCER In 1999 with Actos received FDA approval to treat type II diabetes. Before getting approval for Actos, Takeda knew that it would cause casastrophic side effects, including bladder cancer. Animal studies showed a signal for bladder cancer risk. Takeda knew that they should have studied the bladder cancer risk further. […]
